Hamel Associates’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-10,475
Closed -$759K 94
2017
Q4
$759K Sell
10,475
-7,375
-41% -$536K 0.36% 51
2017
Q3
$1.45M Buy
17,850
+12,800
+253% +$1.01M 0.71% 41
2017
Q2
$406K Buy
+5,050
New +$399K 0.2% 65

Other funds holding CVS

Hamel Associates's CVS Position: Q1 2018 in Review

Hamel Associates sold out of CVS Health (CVS) in Q1 2018, closing a stake of 10,475 shares — an estimated $759K sold.

Hamel Associates first reported a position in CVS in Q2 2017 and held it in 3 quarters. The position peaked at $1.45M in Q3 2017. 1,550 funds tracked by Wall St. Rank hold CVS as of Q1 2018.

  • Hamel Associates reported no remaining CVS Health position as of Q1 2018 after selling out during the quarter.
  • Hamel Associates sold 10,475 CVS Health shares in Q1 2018, an estimated $759K.
  • Hamel Associates first reported a position in CVS Health in Q2 2017 and held it in 3 quarters.
  • Hamel Associates's CVS Health position peaked at $1.45M in Q3 2017.
  • 1,550 funds tracked by Wall St. Rank held CVS Health as of Q1 2018.

Based on Hamel Associates's 13F filing for Q1 2018, filed 3 May 2018.